Case Study: Midwestern Healthcare Delivery Organization achieves improved patient safety and automated drug-diversion monitoring with Imprivata

HDO boosts patient safety, automates drug diversion monitoring, and improves compliance with Imprivata

A Midwestern community-based healthcare delivery organization (HDO) faced growing drug diversion risks that threatened patient safety, regulatory compliance, and operational efficiency. Manual, time-consuming reviews of dispensing cabinets, EHRs, and timekeeping systems made it difficult to detect anomalies—an issue that came to a head when unusually large fentanyl withdrawals prompted a DEA visit and underscored the need for scalable visibility and faster investigations.

The HDO implemented Imprivata FairWarning Drug Diversion Intelligence and Imprivata Drug Diversion Monitoring Services, using AI and behavioral analytics to correlate Epic, OmniCell, and Workday data, automatically flag suspicious activity, and have Imprivata analysts triage alerts and open cases. The solution improved diversion detection, reduced false positives and investigation time, increased compliance with DEA guidelines, and freed pharmacy staff to focus on strategic patient-care activities.